Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules

Exclusion Criteria

• •Diagnosed as any other malignant tumor within the 5 years prior to enrollment, except for malignant tumors with low risk of metastasis and death (5-year survival rate\>90%), such as fully treated basal cell or squamous cell skin cancer or cervical cancer in situ.
• •Imaging or pathological confirmation of recurrence and metastasis.
• •Serious infections (CTCAE\>Level 2) occurred within the first 4 weeks of enrollment, such as severe pneumonia, bacteremia, and infection complications that require hospitalization; Symptoms and signs of infection or the need for oral or intravenous antibiotic treatment within 2 weeks prior to enrollment, excluding the use of prophylactic antibiotics.
• •Suffering from severe acute and chronic diseases.
• •Suffering from severe diabetes whose blood sugar cannot be effectively controlled.
• •Patients who are unable to take oral medication, those who are allergic to the ingredients of Huaier granules, and pregnant or lactating women.
• •Drug abusers, or those who suffer from psychological or mental illnesses that may interfere with research compliance.
• •The researcher believes that it is not suitable to participate in this study.